SCHEMBL7144342

SCHEMBL7144342

CC(C)(O)c1ccc(S(N)(=O)=O)o1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
HTT P42858 1/20 0.46
CA2 P00918 18/20 0.36
CA1 P00915 5/20 0.35
CA7 P43166 3/20 0.35
CA14 Q9ULX7 3/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
ABCC9 O60706 1/20 0.34
ABCC8 Q09428 1/20 0.34
KCNJ11 Q14654 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
KCNJ8 Q15842 1/20 0.34
PDK4 Q16654 1/20 0.34
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889494 0.73 MEN1 (0.31) MEN1KMT2A
SCHEMBL13543152 0.70 ALDH1A1 (0.60) ALDH1A1HTTCA2CA1CA7
SCHEMBL2007672 0.69 ALDH1A1 (0.48) ALDH1A1HTTCA2CA1CA7
SCHEMBL1487258 0.67 ALDH1A1 (0.59) ALDH1A1HTTCA2CA1CA7
SCHEMBL18007542 0.67 CA2 (0.40) ALDH1A1HTTCA2
SCHEMBL7365690 0.67 ALDH1A1 (0.41) ALDH1A1KMT2A
SCHEMBL2735690 0.66 TDP1 (0.48) ALDH1A1HTTMEN1KMT2A
SCHEMBL19475512 0.66 CA2 (0.37) ALDH1A1HTTCA2CA1CA7
SCHEMBL3022289 0.65 ALDH1A1 (0.50) ALDH1A1HTTCA2CA1CA7
SCHEMBL10129375 0.65 CCR2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1127479-C Sulfonylurea derivatives and their use in the control of interleukin-1 activity PFIZER (US) 2003-11-12 CN disclosed
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
EP-1214087-A1 COMBINATION TREATMENT WITH IL-1RA AND COMPOUNDS THAT INHIBIT IL-1 PROCESSING AND RELEASE Pfizer Products Inc. (US) 2002-06-19 EP disclosed
WO-2001019390-A1 COMBINATION TREATMENT WITH IL-1RA AND DIARYL SULPHONYL UREA COMPOUNDS PFIZER PRODUCTS INC. (US) 2001-03-22 WO disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed
CN-1245490-A Sulfonyl urea derivatives and their use in control of interleukin-1 activity PFIZER (US) 2000-02-23 CN disclosed